Introduction
Increased lipoxygenation of arachidonic acid has been implicated in the pathophysiology of psoriasis [12] . Among lipoxygenase products, 12-hydroxy-5,8,1 O,l4-eicosatetraenoic acid (12-HETE) is present in the highest amounts in psoriatic lesions [lo] . 12-HETE is chemotactic to neutrophils in vitro [7] and topical application of 12-HETE to normal human skin results in an erythematous response characterized by a neutrophil and mononuclear cell infiltrate [6] . Therefore, 12-HETE may be one of the mediators of the leukocyte infiltrate characterizing psoriasis.
While 12-HETE may contribute to the pathogenesis of psoriasis, the cellular source of 12-HETE in the psoriatic lesion has not been defined. Normal human epidermis produces predominantly 12-HETE among lipoxygenase products [I 1,151. On the other hand, the neutrophil also present in psoriatic epidermis displays abundant 5-lipoxygenase activity, but no or little 12-lipoxygenase activity [2] . In contrast, platelets can produce substantial amounts of 12-HETE [9] . Activated platelets may, therefore, contribute to the abnormal levels of 12-HETE in psoriatic skin. An activation of platelets might also make psoriatics more prone to occlusive, vascular disease, the incidence of which has been reported to be high in psoriatics [19] .
In this study, we present evidence that aggregation and arachidonic acid metabolism of platelets are stimulated in psoriasis and that platelet-derived 12-HETE increases the DNA synthesis of cultured human keratinocytes. 
Patients
Peripheral venous blood was drawn from 15 adult psoriatics (10 males and 5 females) who had not been treated for at least 2 weeks. Patients were divided into two groups based on whether they had a skin involvement of more or less than 10% of the body surface. Patients taking nonsteroidal antiinflammatory drugs, smokers, and diabetics were all excluded. Fifteen healthy adult volunteers (t 1 males and 4 females) with an age range similar to that of the psoriatics served as volunteers.
PlaWlets
Sodium EDTA blood was centrifuged at 120 • for 15 rain to obtain platelet-rich plasma, which was further centrifuged at 1000 • g for 15 mill to pellet the platelets. Platelets were resuspended in PBS without Ca 2+ or Mg 2+ (pH7), counted in a hemocytometers, and diluted to 2 • 108 cells/ml.
Arachidonic acM metabolites
Suspended platelets were mixed with 2 gM arachidonic acid (Sigma) and 2 mM Ca 2+ for 5 rain at 37~ and then incubated with 1 gM A23187 (Calbiochem) or 10U/ml thrombin for 15 rain at 27~ Arachidonic acid and A23187 were diluted in ethanol (final concentration <0.2%). The incubation was stopped by adding 2 vols ice-cold methanol. After removal of denatured proteins by centrifugation at 600 • g for 15 rain, lipids were extracted using a modification of the method described by Luderer et al. [17] . Samples were acidified to pH 3 with 2 N formic acid, applied to octadecylsilyl (ODS) silica columns (Waters Assoc.), and eluted sequentially with water, petroleum ether, and methanol under vacuum. The methanol fraction was analyzed using reversed-phase high-performance liquid chromatography (RP-HPLC) (Hewlett Packard 1090 liquid chromatograph) on a Hypersil ODS column (100 • 2:1 ram) eluted with acetonitrile (ACN) in aqueous phosphoric acid (pH 3). The mobile phase was 20% ACN with a linear increase to 30% over 2 rain followed by linear increases to 33% from 2 to 10 rain, to 53% from 10 to 18 rain, to 57% from 18 to 23 rain, and to 85% from 23 to 28 min. From 28 to 33 rain the ACN was kept at 85%. The solvent was defivered at a rate of 0.8 ml/min. The UV spectrum was produced for each chromatographic peak generated. 12-Hydroxy-5,8,I0-heptadecatrienoic acid (HHT) and 12-HETE were used as markers of the cyclooxygenase and the 12-1ipoxygenase pathways, respectively.
Authentic standards of 12-HETE and HHT derived from platelets were provided by Dr. S. Hammarstr6m (Department of Physiological Chemistry, Karolinska Institutet, Stockholm, Sweden). Identification of 12-HETE and HHT was based on cochromatography with authentic standards and on their UV spectrum.
Platelet aggregation
Aggregation was measured with a chronolog electronic aggregometer; 1 ml of platelets (2 • 10S/ml) in Ca 2 +/Mg z+-free PBS was prewarmed to 37~ for 5 rain. Aggregation was initiated by adding thrombin (1 or 10 U/ml), ADP (0.5 gg/ml), or ristocetin (1 mg/ml) under continuous stirring. Two electrodes were placed in the platelet suspension, and aggregation was read as the increase in impedance as platelets accumulated on the electrodes. Results were expressed as the aggregation after 3 min divided by the maximal aggregation.
DNA synthesis of cultured human keratinocytes
Primary cultures of adult human epidermal keratinocytes were established as previously described [13] . Ethanolic dilutions of 12-HETE (ethanol < 0.1%) were added to confluent cultures for 72 h. DNA synthesis was determined as (3H) thymidine incorporation into DNA and as autoradiographic labeling indices, as previously described [/6]. (12-HETE) by platelets from normals and psoriatics. Two milliliters of platelets (2 • 108/mi) was incubated with 2 gM arachidonic acid and 1 ~tM A23187 for 15rain at 37~ 12-HETE was isolated using reversed-phase high-performance liquid chromatography (RP-HPLC) and quantified by integrated optical density. The mean value is indicated by a horizontal bar. Normal vs. psoriasis (>10% of body surface), P < 0.01
Statistics
Statistical significance was assessed using the Wilcoxon ranksum test for unpaired data. A P value below 0.05 was considered significant.
Results
In Fig. 1 the formation of 1 2 -H E T E by normal and psoriatic platelets can be seen. Psoriatics with widespread diseases (~> 10% o f the b o d y surface) formed on average 125% more 1 2 -H E T E than normals, whereas patients with mild disease ( < 10% o f the b o d y surface involved) had normal 12-1ipoxygenase activity. The formation o f H H T , a marker o f cyclooxygenase activity, was also stimulated in widespread psoriasis (Fig. 2 ), although to a lesser degree (98%) than 12-H E T E . Platelet aggregation was elicited by adding thrombin (1 U/ml), A typical response o f normal and psoriatic platelets is shown in Fig. 3 . Psoriatic platelets showed an increased rate o f aggregation, but the maximal aggregation was normal. Expressing aggregation as the aggregation obtained after 3 min, a shortened platelet aggregation time was present in both mild and widespread disease (Fig. 4) . The aggregation of psoriatic platelets was also enhanced in response to a higher thrombin concentration (10 U/ml) To assess whether platelet-derived 12-HETE modifies keratinocyte DNA synthesis, 12-HETE was added to cultured human keratinocytes (Fig. 5) . Addition of 12-HETE resulted in a dose-dependent stimulation of (3H) thymidine incorporation into DNA. At concentrations higher than lop6 M, no stimulation of the DNA synthesis was observed. The stimulation was maximal (68%) at l o w 7 M. At concentrations of lo-' M or higher, the keratinocyte DNA was not affected by 12-HETE (Fig. 5) .
The ability of 12-HETE to stimulate keratinocyte DNA synthesis was confirmed by determining autoradiographic labeling indices (data not shown). 
Discussion
From the results of this study, it appears that platelet aggregation and arachidonic acid metabolism are stimulated in psoriatics with active disease. Hyperaggregatory platelets have also been reported in patients with diabetes mellitus [5] and in cigarette smokers [16] . Furthermore, the 12-lipoxygenase activity of platelets can be stimulated by cigarette smoking [4]. Since both diabetics and smokers were excluded from our study, the increased platelet activities in the patients studied by us seem to be related to their psoriasis. However, other factors not controlled for in the study may also be involved. The transformation of arachidonic acid via 12-lipoxygenase was stimulated to a higher degree than via cyclooxygenase in psoriatic patients; 12-lipoxygenase activity results in the formation of 12-HETE, which was shown to stimulate the DNA synthesis of cultured human keratinocytes. As observed with leukotrienes [14] , the stimulatory effect of 12-HETE on the DNA synthesis of keratinocyte cultures was only present at low concentrations. Combined with the ability of platelet-derived 12-HETE to induce an erythematous skin response characterized by neutrophil accumulation in humans [6] , our findings are compatible with the idea that a i2-Iipoxygenase product ofplatelets may participate in the pathophysiology of psoriasis. This increased 12-HETE formation by psoriatic platelets may explain why increased 12-HETE release has been reported in psoriatic neutrophil suspensions contaminated with platelets [22] . In addition, an increased platelet contamination may have contributed to these results.
Products of the 12-1ipoxygenase pathway do not participate in the aggregation of platelets [21] . In contrast, certain cyclooxygenase products, particularly thromboxane A2, are potent proaggregatory agents [8] . Release of thromboxane A2 may be responsible for the enhanced platelet aggregation induced by thrombin in psoriasis. In addition, other metabolic pathways leading to platelet aggregation appear to be activated in psoriasis, because we found no significant correlation between cyctooxygenase activity and aggregation in psoriatic platelets. Recently, psoriatic patients have been found to have increased whole blood viscosity [23] , enhanced spontaneous platelet aggregation [1] , and enhanced platelet regeneration time [1 ] . Combined with the stimulated platelet activities that we found, these results indicate that psoriatics may be prone to develop occlusive vascular disease. These experimental data are in accordance with a retrospective study in which the incidence of occlusive vascular disease was higher in psoriatic patients than in nonpsoriatic dermatological patients [19] . It should, however, be borne in mind that carefully designed prospective studies are required to decide not only whether occlusive vascular disease is in fact more common in psoriatics, but also to control for other conditions that may be associated with an increased risk of thrombosis.
On a molar basis 12-HETE was 100--1000 times less potent than leukotriene B4 [14] in stimulating DNA synthesis of cultured human keratinocytes. The ratio of 12-HETE to leukotriene B~ in psoriatic lesions is, however, of the same order of magnitude. As a consequence, the biological effects of 12-HETE in psoriatic lesions may be as pronounced as those of leukotriene B~. Epidermis itself is also capable of synthesizing 12-HETE [11, 15] , although there is recent evidence that 12-HETE present in psoriatic epidermis may be stereochemically different from platelet-derived 12-HETE [24] . In the future, therefore, it would be of interest to determine whether epidermis-derived 12-HETE also possesses mitogenic activity. Platelets contain other mitogenic factors th~n 12-HETE [20] . Whether these mitogens also affect epidermal keratinocyte proliferation is not known.
Although this study has demonstrated abnormalities of peripheral platelets from patients with psoriasis, a key question is to what extent platelets or their products are present in lesional psoriatic skin. In electron microscopic studies, the microvascular system of psoriatic skin displays various abnormalities, consisting of dilatation and convolution of the capillary loops with endothelial gaps [3] . Thrombosis is, however, not part of the histopathological picture of psoriasis, and platelets are apparently not plentiful in psoriatic lesions [3] . As mentioned above, it may now be possible to make a distinction between epidermal and platelet-derived 12-HETE. Using platelet-specific 12-HETE as a marker of platelets, it may, therefore, be possible to decide whether platelets are involved in the psoriatic skin lesion. Also, it remains to be determined whether the platelet abnormalities are specific for psoriasis or shared by other inflammatory dermatoses.
